|
|
Volumn 29, Issue 1-2, 1997, Pages 614-615
|
|
Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GROWTH FACTOR;
LEFLUNOMIDE;
RAPAMYCIN;
TACROLIMUS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BRONCHIOLITIS;
CELL PROLIFERATION;
CONFERENCE PAPER;
DRUG MECHANISM;
GRAFT OCCLUSION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART LUNG TRANSPLANTATION;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG FIBROBLAST;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ADULT;
BRONCHIOLITIS OBLITERANS;
CELL DIVISION;
CELL LINE;
DNA;
FIBROBLASTS;
GRAFT REJECTION;
GROWTH SUBSTANCES;
HEART-LUNG TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LUNG;
LUNG TRANSPLANTATION;
POLYENES;
SIROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0030936750
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00325-9 Document Type: Conference Paper |
|
Times cited : (40)
|
|
References (3)
|
